Revive Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 10 Jul 24 | BuyUS$3,670 | Andrew Lindzon | Individual | 333,000 | US$0.011 | |
| 03 Jul 24 | BuyUS$3,669 | Michael Frank | Individual | 500,000 | US$0.0073 | |
| 19 Mar 24 | BuyUS$2,580 | Michael Frank | Individual | 100,000 | US$0.026 | |
| 18 Mar 24 | BuyUS$3,876 | Michael Frank | Individual | 150,000 | US$0.026 | |
| 15 Mar 24 | BuyUS$7,139 | Michael Frank | Individual | 322,000 | US$0.022 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 25,000 | 0.00597% |
| Individual Insiders | 6,952,534 | 1.66% |
| General Public | 411,586,735 | 98.3% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17%.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 3,138,500 | US$22.4k | 19% | no data | |||
| 2,000,000 | US$14.3k | 0% | no data | |||
| 650,000 | US$4.6k | 0% | no data | |||
| 625,334 | US$4.5k | 0% | no data | |||
| 538,700 | US$3.8k | 162% | no data | |||
| 25,000 | US$178.3 | 0% | no data |